The potential of neratinib plus dasatinib in overcoming and preventing neratinib resistance in HER2-positive breast cancer models

Conlon, N; Browne, A; Breen, L; Lowry, M; O'Driscoll, L; Cremona, M; Hennessy, BT; Eustace, AJ; O'Donovan, N; Crown, J; Collins, DM

ANNALS OF ONCOLOGY, 2019; 30 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索